Efficacy, tolerability and safety of mirtazapine in the treatment of patients with moderate or severe major depression

被引：0
|
作者：
Iglesias, G
Mendoza, A
Ortega, M
Flores, J
Borges, HL
García, J
Martínez, D
Márquez, G
Iacobelli, M
Pavón, L
机构：
[1] Hosp Mil Dr Carlos Arvelo, Dept Psychiat, Caracas, Venezuela
[2] Humana Desarrollos Bienestar Integral CA, Caracas, Venezuela
[3] Organon Venezolana, Dept Med, Caracas, Venezuela
[4] Clin Florida, Caracas, Venezuela
来源：
JOURNAL OF AFFECTIVE DISORDERS | 2004年 / 78卷
关键词：
depression; antidepressants; mirtazapine;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [1] Mirtazapine: Efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder
    Wheatley, DP
    van Moffaert, M
    Timmerman, L
    Kremer, CME
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (06) : 306 - 312
  • [2] Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
    Fawcett, J
    Barkin, RL
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1998, 51 (03) : 267 - 285
  • [3] Efficacy and tolerability of mirtazapine in the treatment of major depression due to Parkinson disease.
    Weiser, R
    Hernandez-Rojas, J
    Gallardo, M
    García, ML
    Grau, M
    Flores, J
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S190 - S191
  • [4] Efficacy and tolerability of Escitalopram in patients with mild, moderate and severe depression
    Stamouli, S.
    Yfantis, A.
    Zouganelli, A.
    Lampousis, E.
    Giailoglou, D.
    Parashos, I.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 320 - 320
  • [5] Efficacy and tolerability of patients' treatment with moderate to severe depression with trazodone in comparison to SSRI/SNRI
    Khaustova, O.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S277 - S277
  • [6] Tolerability of mirtazapine versus SSRIs in patients with major depression
    Willigenburg, APP
    Schutte, AJ
    van der Flier, S
    Vester-Blokland, E
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S141 - S142
  • [7] Tolerability of mirtazapine versus SSRIs in patients with major depression
    Braber, ED
    Schutte, AJ
    Van der Flier, S
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S253 - S253
  • [8] Efficacy, tolerability and safety of mirtazapine in the treatment of major depressive disorder due to Parkinson disease
    Iglesias, G
    Weiser, R
    Hernández-Rojas, J
    Flores, J
    Gallardo, M
    García, LM
    Grau, M
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S119 - S119
  • [9] Efficacy, tolerability and safety of mirtazapine in the treatment of major depressive disorder due to Parkinson disease
    Weiser, R
    Hernadez-Rojas, J
    Flores, J
    Gallardo, M
    Garcia, M
    Grau, M
    [J]. MOVEMENT DISORDERS, 2004, 19 : S205 - S205
  • [10] A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression
    Marttila, M
    Jaaskelainen, J
    Jarvi, R
    Romanov, M
    Miettinen, E
    Sorri, P
    Ahlfors, U
    Zivkov, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1995, 5 (04) : 441 - 446
12345